351–400 of 20,598 genesranked by Most Researched

#	Gene	Name	Chr	Tags	PubMed Papers
351	ATR	ATR checkpoint kinase	3	DNA RepairKinase	641
352	RUNX2	RUNX family transcription factor 2	6	OMIM Disease GeneHighly Studied	641
353	KCNQ1	potassium voltage-gated channel subfamily Q member 1	11	Ion ChannelTransporter	639
354	APOBEC3G	apolipoprotein B mRNA editing enzyme catalytic subunit 3G	22	Highly StudiedExperimental GO Evidence	637
355	NF1	neurofibromin 1	17	Tumor SuppressorOMIM Disease Gene	637
356	EPAS1	endothelial PAS domain protein 1	2	FDA Approved TargetOMIM Disease Gene	636
357	SUMO1	small ubiquitin like modifier 1	2	OMIM Disease GeneHighly Studied	636
358	XPO1	exportin 1	2	Highly ConstrainedTransporter	635
359	PROM1	prominin 1	4	OMIM Disease GeneHighly Studied	631
360	HSP90AB1	heat shock protein 90 alpha family class B member 1	6	Clinical TrialsHighly Studied	629
361	THBS1	thrombospondin 1	15	Highly ConstrainedHighly Studied	629
362	TYMS	thymidylate synthetase	18	FDA Approved TargetOMIM Disease Gene	629
363	HNRNPK	heterogeneous nuclear ribonucleoprotein K	9	Highly ConstrainedOMIM Disease Gene	628
364	RACK1	receptor for activated C kinase 1	5	Highly ConstrainedHighly Studied	628
365	CALM1	calmodulin 1	14	FDA Approved TargetHighly Studied	627
366	C9orf72	C9orf72-SMCR8 complex subunit	9	OMIM Disease GeneHighly Studied	626
367	CD40	CD40 molecule	20	ReceptorClinical Trials	626
368	MYD88	MYD88 innate immune signal transduction adaptor	3	ApoptosisOMIM Disease Gene	624
369	UBE2D1	ubiquitin conjugating enzyme E2 D1	10	Highly StudiedExperimental GO Evidence	624
370	GAPDH	glyceraldehyde-3-phosphate dehydrogenase	12	Highly StudiedExperimental GO Evidence	623
371	RIGI	RNA sensor RIG-I	9	OMIM Disease GeneHighly Studied	621
372	VCAM1	vascular cell adhesion molecule 1	1	Highly StudiedExperimental GO Evidence	621
373	OPRM1	opioid receptor mu 1	6	ReceptorFDA Approved Target	620
374	DPP4	dipeptidyl peptidase 4	2	ProteaseReceptor	619
375	TGFBR2	transforming growth factor beta receptor 2	3	ApoptosisKinase	617
376	CHEK1	checkpoint kinase 1	11	DNA RepairKinase	616
377	FBXW7	F-box and WD repeat domain containing 7	4	DNA RepairHighly Constrained	616
378	FGFR3	fibroblast growth factor receptor 3	4	KinaseReceptor	616
379	SKP1	S-phase kinase associated protein 1	5	Highly ConstrainedHighly Studied	616
380	DNMT3A	DNA methyltransferase 3 alpha	2	FDA Approved TargetOMIM Disease Gene	613
381	TGFBR1	transforming growth factor beta receptor 1	9	KinaseReceptor	612
382	YWHAE	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon	17	Highly ConstrainedHighly Studied	612
383	CCN2	cellular communication network factor 2	6	Clinical TrialsOMIM Disease Gene	611
384	GRN	granulin precursor	17	OMIM Disease GeneHighly Studied	611
385	FASN	fatty acid synthase	17	Highly ConstrainedHighly Studied	610
386	MMP14	matrix metallopeptidase 14	14	Highly ConstrainedProtease	609
387	BMI1	BMI1 proto-oncogene, polycomb ring finger	10	OncogeneHighly Studied	606
388	UBE2I	ubiquitin conjugating enzyme E2 I	16	Highly ConstrainedHighly Studied	606
389	SHH	sonic hedgehog signaling molecule	7	ProteaseOMIM Disease Gene	605
390	NBN	nibrin	8	DNA RepairHomologous Recombination	604
391	SKP2	S-phase kinase associated protein 2	5	Highly StudiedExperimental GO Evidence	604
392	HNRNPA1	heterogeneous nuclear ribonucleoprotein A1	12	TransporterOMIM Disease Gene	602
393	IFNL3	interferon lambda 3	19	Highly StudiedExperimental GO Evidence	601
394	IL12B	interleukin 12B	5	FDA Approved TargetOMIM Disease Gene	601
395	CCNB1	cyclin B1	5	Highly StudiedExperimental GO Evidence	599
396	TRIM28	tripartite motif containing 28	19	DNA RepairHighly Constrained	599
397	LTA	lymphotoxin alpha	6	OMIM Disease GeneHighly Studied	598
398	PLAU	plasminogen activator, urokinase	10	ProteaseFDA Approved Target	596
399	HNF4A	hepatocyte nuclear factor 4 alpha	20	ReceptorTranscription Factor	592
400	TRAF2	TNF receptor associated factor 2	9	Highly ConstrainedHighly Studied	592